Alpha-CMV Allele Confers CMV Resistance in Spinach

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current spinach cultivars lack a characterized genetic basis for resistance to Cucumber Mosaic Virus (CMV), relying on phenotypic assays for resistance identification, and there are no known molecular markers for CMV resistance in spinach.

Innovation Solution

Identification of a CMV resistance allele, alpha-CMV, located at the same locus as Peronosporafarinosa f. sp. spinaciae resistance alleles, which encodes a CC-NBS-LRR protein with specific motifs, allowing for molecular tools to confer resistance to CMV in spinach plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If phenotypic assays are used to identify CMV resistance in spinach, then resistance can be detected, but the process is time-consuming and labor-intensive requiring screening of many accessions

Engineering Contradiction:
Improveresistance identification accuracyVSAvoidscreening time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical/phenotypic assay system with a molecular detection system. Specifically, it uses DNA sequencing to identify the alpha-CMV allele and molecular markers (SNPs, SSRs) to detect resistance, substituting physical disease symptom observation with genetic analysis. This allows resistance identification at the molecular level without requiring time-consuming phenotypic screening in disease tests.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent performs preliminary genetic characterization to identify the alpha-CMV allele and linked molecular markers before phenotypic testing. By establishing molecular markers (such as SNPs and SSRs) that are closely linked to the resistance allele, the system enables preliminary screening and selection of resistant plants at the DNA level, avoiding the need to grow and test numerous accessions under disease conditions.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If molecular markers are developed for CMV resistance, then resistance identification becomes more efficient, but the complexity of molecular analysis increases

Engineering Contradiction:
Improveresistance screening efficiencyVSAvoidmolecular analysis complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent extracts specific molecular markers (SNPs, SSRs) that are closely linked to the alpha-CMV resistance allele from the complex genome. By identifying and isolating these specific marker loci, the system enables targeted molecular analysis rather than whole-genome sequencing, simplifying the detection process while maintaining high screening efficiency. The markers serve as proxies for the resistance allele, making detection straightforward.

Inventive Principle:
Principle #2Taking out (Extraction)

3Loss of information

If the genetic basis of CMV resistance is characterized, then molecular tools for resistance identification become available, but the initial research and development time is required

Engineering Contradiction:
Improvegenetic information availabilityVSAvoidresearch development time
Core Design Contradiction:
Loss of informationVSLoss of time

Solution Approach 1:

The patent performs preliminary genetic research to fully characterize the alpha-CMV allele, including its nucleotide sequence, amino acid sequence, and linkage to molecular markers. This upfront investment in genetic characterization creates a reusable knowledge base and diagnostic toolset that can be applied indefinitely for resistance identification, eliminating the need for repeated research efforts and enabling long-term efficient screening programs.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP3688016B1CMV resistance allele
Publication Date: 2024.01.31 RIJK ZWAAN ZAADTEELT & ZAADHANDEL BV
  • EP3688016B1 patent drawing
  • EP3688016B1 patent drawing
  • EP3688016B1 patent drawing

AI summary

The present invention relates to an allele designated alpha-CMV which confers resistance to CMV when present in a spinach plant, wherein the protein encoded by said allele is a CC-NBS-LRR protein that comprises in its amino acid sequence: a) the motif "MAEIGYSVC" at its N-terminus; and b) the motif "KWMCLR"; and c) an LRR domain that has in order of increased preference at least 95%, 96%, 97%, 98%, 99%, 100% sequence similarity to SEQ ID No:10. The allele has a genomic nucleotide sequence which in order of increased preference has at least 80%, 81%, 82%, 83%, 84%,85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 100% sequence similarity to SEQ ID No:1. The invention further relates to plants comprising the allele and to various methods involving the allele.